Article Sidebar

Download
View Article
Statistic
Read Counter : 44 Download : 28

Main Article Content

Abstract

Background: The most common medical condition in low-, middle-, and high-income countries is obesity. Thus, diet, lifestyle, and anti-obesity drugs are becoming popular adjuvant treatments for this medical condition. Knowing the community's opinion and awareness is crucial. Materials and methods: This cross-sectional study was conducted at Al-Diwaniyah province hospitals. A convenience sample of 200 health care workers in Al-Diwaniyah province hospitals who are enrolled in the three hospitals (Al-Diwaniyah teaching, the general Al-Hamiza, and the general Al-Shamia). This study includes health care workers (HCWs) of both genders and ages over 20 years of morning shift. While this study excludes those with an educational level below secondary school, administrative staff were excluded from the study. The data collect started from the 3rd of November 2023 till the 13th of February 2024. Results: The results of this study indicate that 52.5% of health workers have a moderate awareness score, followed by 24.5% of the participants have a poor awareness score, and only 23.0% of HCWs have a good awareness score. the results of this study reveal that there is significant relationship between demographic characteristics and overall awareness score (P. value <0.05), except for residence. Conclusions: The study report that most HCWs have a moderate awareness about anti-obesity drugs. These results explain that old age, males’ gender, high education and physician have good assessment scores for awareness about anti-obesity drugs. The study recommends developing and focusing on community-based educational programs and campaigns on anti-obesity medications to improve their views on obesity management.

Keywords

Obesity medications health care workers

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite
Merhej, S. A. A., & Sawafi, A. G. A. (2024). AWARENESS OF HEALTH CARE WORKERS TOWARDS ANTI-OBESITY MEDICATIONS IN A SAMPLE OF HOSPITALS IN AL-DIWANIYAH PROVINCE, IRAQ. Journal of Medical Genetics and Clinical Biology, 1(8), 77–88. https://doi.org/10.61796/jmgcb.v1i8.823
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. . Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism. 2019;92:6–10.
  2. . World Health Organization. Obesity and overweight [Internet]. WHO. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
  3. . Semlitsch T, Stigler FL, Jeitler K, Horvath K, Siebenhofer A. Management of overweight and obesity in primary care—A systematic overview of international evidence‐based guidelines. Obes Rev. 2019;20(9):1218–30.
  4. . Ahirwar R, Mondal PR. Prevalence of obesity in India: A systematic review. Diabetes Metab Syndr Clin Res Rev. 2019;13(1):318–21.
  5. . Bragg R, Crannage E. Review of pharmacotherapy options for the management of obesity. J Am Assoc Nurse Pract. 2016;28(2):107–15.
  6. . Kahan S. Overweight and obesity management strategies. Am J Manag Care. 2016;22(7 Suppl):s186-96.
  7. . Gadde KM, Pritham Raj Y. Pharmacotherapy of obesity: clinical trials to clinical practice. Curr Diab Rep. 2017;17:1–9.
  8. . Idrees Z, Cancarevic I, Huang L. FDA-approved pharmacotherapy for weight loss over the last decade. Cureus. 2022;14(9).
  9. . Shareef RH, Al-Sarray AAM. COVID-19 Vaccination Knowledge Among a Sample of Healthcare Providers in Karbala Governorate. NeuroQuantology. 2022;20(6):4539.
  10. . Sharaf S, Al-shalabi BT, Althani GF, Bazuhair HM, Fairaq BJ, Ali FA. Obesity self-management: knowledge, attitude, practice, and pharmaceutical use among healthy obese individuals in Saudi Arabia. Int J Fam Community Med. 2021;5(4):110–21.
  11. . Almughais ES, Alshehri MH, Alsatti M, Almatar A, Albladi FH, Almomatin HH, et al. Awareness and perception of anti-obesity medications among Al-Ahsaa, Riyadh, and Hail in Saudi Arabia populations. Cureus. 2023;15(6).
  12. . Alhawiti RM. Knowledge, attitude, and practice about obesity among adults (18-45 years) in primary health care in Medina, KSA 2019. Int J Med Dev Ctries. 2021;5(2):648.
  13. . de Souza Filho MD, Moura FS, de Carvalho J de SR, Müller MC, Neves RV, Mousinho PC, et al. Use of anti-obesity drugs among college students. Rev da Assoc Médica Bras (English Ed. 2011;57(5):558–64.
  14. . Lee PC, Ganguly S, Tan HC, Lim CH, Chan WH, Kovalik J-P, et al. Attitudes and perceptions of the general public on obesity and its treatment options in Singapore. Obes Res Clin Pract. 2019;13(4):404–7.
  15. . Cook NS, Tripathi P, Weiss O, Walda S, George AT, Bushell A. Patient needs, perceptions, and attitudinal drivers associated with obesity: a qualitative online bulletin board study. Adv Ther. 2019;36:842–57.
  16. . Bessesen DH, Van Gaal LF. Progress and challenges in anti-obesity pharmacotherapy. lancet Diabetes Endocrinol. 2018;6(3):237–48.
  17. . Jasim UT, Ebrahim SM, Ajimi ES, Hassan ZS. Knowledge and use of anti-obesity medications among students at Basrah University. Eurasian Med Res Period. 2023;17:79–86.
  18. . Parildar H, Tuncer OU, Sahin MK, Demirpençe M, Yilmaz H. Are patients with obesity “scapegoats”? The obesity prejudice levels of health care workers in Turkey. Rev Assoc Med Bras. 2021;67:1785–92.
  19. . Ozcelik M, Uzunlulu M, Kizilgul M, Oguz A, Antika T. The awareness of abdominal obesity and metabolic syndrome in healthcare workers. J Endocrinol Metab. 2013;3(3):57–61.
  20. . SARI H, KILINÇ Z, Soysal Ş, Özel M. Evaluation of the frequency and awareness of obesity among healthcare workers. Eur Rev Med Pharmacol Sci. 2023;27(10).